Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00895427 · ClinicalTrials.gov registry record
A Study Comparing Skin Fluorescence to Coronary Artery Calcification
A clinical trial of Diabetes and Coronary Artery Calcification, sponsored by VeraLight.
- Completed
- Registry status
- 240
- Enrollment target
- 1
- Study location
NCT00895427 is a study of Diabetes and Coronary Artery Calcification that has completed, run by VeraLight. The registered enrollment target is 240 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00895427, a study of Diabetes and Coronary Artery Calcification, has completed, sponsored by VeraLight.
- COMPLETED
- Registry status
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
This study examines the relationship between the SCOUT DM device and coronary artery calcification as determined by rapid computed tomography in patients at risk for coronary heart disease.
Conditions Studied
Study Locations (1)
New Mexico
- New Mexico Heart Institute - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2009-02 |
| Est. Completion | 2011-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00895427
The ClinicalTrials.gov registry entry for NCT00895427 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (92% lower). The listed sponsor is VeraLight, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Diabetes appearing as the primary indexed condition, and to 0 interventions.
NCT00895427 reports 1 study location spanning 1 distinct geographic area - top geographies include New Mexico.
Frequently Asked Questions
What is clinical trial NCT00895427 about?
NCT00895427 is a clinical study titled "A Study Comparing Skin Fluorescence to Coronary Artery Calcification". This study examines the relationship between the SCOUT DM device and coronary artery calcification as determined by rapid computed tomography in patients at risk for coronary heart disease.
What is the current status of trial NCT00895427?
This trial is currently completed. The enrollment target is 240 participants. The study started on 2009-02. Estimated completion is 2011-09.
What conditions does trial NCT00895427 study?
This clinical trial studies the following conditions: Diabetes, Coronary Artery Calcification.
Who is sponsoring clinical trial NCT00895427?
This trial is sponsored by VeraLight, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00895427 being conducted?
This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
RECRUITING
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Taste Bud-Derived Stem Cells in Humans
RECRUITING
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.